Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210033247 210011040 null 50 Palliative (P) 2018-12-11 2018-12-22 Bendamustine+Rituximab(Sub Courses) N N 210028183 BENDAMUSTINE + RITUXIMAB
210033248 210011045 1.6 111.3 Disease modification (D) 2018-09-02 2018-09-03 FCR N N 210028194 FCR
210033249 210011048 1.77 null Palliative (P) null 2016-02-10 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 02 N 210028218 FCR
210033250 210011080 null 51.3 null 2015-04-07 2015-07-01 FLAIR Trial N N 210028309 FLAIR TRIAL
210033251 210011081 1.77 82.3 Disease modification (D) 2015-04-03 2015-05-11 BENDAMUSTINE + RITUXIMAB 02 Y 210028320 BENDAMUSTINE + RITUXIMAB
210033252 210011093 null null Palliative (P) 2015-08-11 2015-12-24 BENDAMUSTINE + RITUXIMAB 2 N 210028382 BENDAMUSTINE + RITUXIMAB
210033253 210034998 1.79 88 Disease modification (D) 2017-08-25 2017-12-11 FLAIR Trial 01 N 210028415 FLAIR TRIAL
210033254 210011105 null 72.3 Curative (C) 2017-12-29 2017-12-29 Vincristine (weekly) N N 210028430 VINCRISTINE
210033255 210021184 1.18 69.3 null 2018-10-14 2018-10-14 Vincristine (weekly) null N 210028437 VINCRISTINE
210033256 210011114 1.54 72.4 Curative (C) 2014-09-15 2014-11-27 Bendamustine+Rituximab(Sub Courses) N N 210028468 BENDAMUSTINE + RITUXIMAB
210033257 210021190 1.72 53.95 Curative (C) null 2016-03-05 FCR Oral - Cycle 2 onwards N N 210028497 FCR
210033258 210011128 null 44.7 Palliative (P) 2013-03-18 2013-07-01 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB Y N 210028532 FCR
210033259 210011130 1.9 62.3 Palliative (P) 2015-07-25 2016-08-11 BENDAMUSTINE + RITUXIMAB N N 210028533 BENDAMUSTINE + RITUXIMAB
210033260 210011138 1.6 58.9 Palliative (P) 2015-03-02 2015-03-02 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210028548 FCR
210033261 210011152 1.29 33.5 null 2018-06-24 2018-06-24 FCR Oral - Cycle 2 onwards 2 N 210028584 FCR
210033262 210036101 null 23.25 Not known (9) 2013-11-25 2014-02-27 FLAIR Trial 1 N 210028604 FLAIR TRIAL
210033263 210011163 1.79 100.7 Curative (C) null 2014-04-15 FCR Oral - Cycle 2 onwards N N 210028621 FCR
210033264 210027363 null 74.45 Palliative (P) 2014-06-16 2014-07-14 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210028634 FCR
210033265 210011170 1.51 73.1 Curative (C) 2016-07-03 2016-07-14 FCR Oral - Cycle 2 onwards N N 210028647 FCR
210033266 210021217 1.67 96 null 2016-07-18 2016-09-23 Vincristine (weekly) N N 210028649 VINCRISTINE
210033267 210011185 1.62 86.7 Curative (C) 2016-03-10 2016-04-08 FLAIR Trial N N 210028709 FLAIR TRIAL
210033268 210011192 1.8 12.7 Curative (C) 2018-04-19 2018-06-01 FLAIR Trial 2 N 210028734 FLAIR TRIAL
210033269 210011217 1.83 134.2 Palliative (P) 2017-02-12 2018-07-14 BENDAMUSTINE + RITUXIMAB N N 210028809 BENDAMUSTINE + RITUXIMAB
210033270 210021241 1.65 130 Curative (C) null 2013-07-15 Bendamustine+Rituximab(Sub Courses) N N 210028830 BENDAMUSTINE + RITUXIMAB
210033271 210011238 null 10.5 Palliative (P) 2018-07-11 2018-07-17 BENDAMUSTINE + RITUXIMAB null null 210028874 BENDAMUSTINE + RITUXIMAB
210033272 210011247 1.75 90.6 Palliative (P) 2017-12-19 2018-01-23 FCR Oral - Cycle 2 onwards 2 N 210028897 FCR
210033273 210011252 1.86 106.5 null 2018-01-05 2018-01-08 FCR Oral - Cycle 2 onwards 02 null 210028901 FCR
210033274 210011258 1.9 45 Palliative (P) 2014-07-04 2014-08-18 VINCRISTINE 02 N 210028908 VINCRISTINE
210033275 210021259 1.66 70.4 Curative (C) 2015-03-23 2015-07-06 FCR Oral - Cycle 2 onwards 02 N 210028914 FCR
210033276 210011270 1.79 87 Disease modification (D) 2017-08-24 2017-10-23 Bendamustine+Rituximab(Sub Courses) N N 210028935 BENDAMUSTINE + RITUXIMAB
210033277 210011274 1.83 83 Disease modification (D) 2018-03-11 2018-05-07 FCR Oral - Cycle 2 onwards 2 N 210028939 FCR
210033278 210011282 1.62 69.3 Palliative (P) 2016-10-22 2016-10-23 FCR 02 N 210028981 FCR
210033279 210011289 1.25 45.6 Palliative (P) 2017-05-17 2017-10-12 BENDAMUSTINE + RITUXIMAB N N 210029009 BENDAMUSTINE + RITUXIMAB
210033280 210036883 0 59.4 Disease modification (D) 2015-06-05 2015-06-20 IDELALISIB + RITUXIMAB Y N 210029077 IDELALISIB + RITUXIMAB
210033281 210033435 1.74 73 Palliative (P) 2016-06-16 2016-06-18 ALL UKALL60+ TRIAL 01 N 210029102 UKALL60+
210033282 210011315 1.68 95.1 Adjuvant (A) 2016-01-03 2016-01-03 IDELALISIB + RITUXIMAB N N 210029159 IDELALISIB + RITUXIMAB
210033283 210011320 1.73 70 Curative (C) null 2015-11-19 Imatinib 400mg N N 210029163 IMATINIB
210033284 210011325 1.71 57 Curative (C) 2016-07-13 2016-09-14 IDELALISIB + RITUXIMAB Y N 210029191 IDELALISIB + RITUXIMAB
210033285 210011331 null 57.8 Curative (C) null 2019-02-26 IDELALISIB + RITUXIMAB N N 210029196 IDELALISIB + RITUXIMAB
210033286 210011359 0 42.5 Curative (C) 2017-11-07 2018-07-06 IMATINIB N N 210029276 IMATINIB
210033287 210011364 1.68 84.8 Curative (C) 2016-01-19 2016-01-20 ALL UKALL60+ TRIAL N null 210029291 UKALL60+
210033288 210011386 1.54 null Curative (C) 2017-09-09 2018-01-27 IMATINIB null null 210029359 IMATINIB
210033289 210011400 0 70 Disease modification (D) 2016-06-15 2016-07-22 CHLORAMBUCIL + OBINUTUZUMAB 01 N 210029402 CHLORAMBUCIL + OBINUTUZUMAB
210033290 210011411 null 88.2 Curative (C) 2014-02-23 2014-03-23 METHOTREXATE Y N 210029448 METHOTREXATE
210033291 210011413 null null Curative (C) 2017-08-07 2017-08-07 Imatinib 400mg N null 210029451 IMATINIB
210033292 210011423 1.6 80 Palliative (P) 2018-12-27 2019-02-10 IDELALISIB + RITUXIMAB Y N 210029502 IDELALISIB + RITUXIMAB
210033293 210011488 1.51 null Curative (C) 2018-03-13 2018-03-13 IDELALISIB + RITUXIMAB 2 N 210029804 IDELALISIB + RITUXIMAB
210033294 210011495 1.77 71.5 Curative (C) 2018-07-25 2018-09-22 METHOTREXATE N N 210029832 METHOTREXATE
210033295 210011507 1.75 77.75 Curative (C) 2017-01-09 2017-01-09 METHOTREXATE 02 N 210029884 METHOTREXATE
210033296 210011538 1.68 61.2 null 2018-10-13 2018-10-13 IMATINIB N N 210030000 IMATINIB